Since 2013, we have been heavily investing in CRISPR/Cas9-based mouse model development, and have designed a unique offer, combining our:
- Expertise in model design
- Rigorous quality controls for mouse models
With the advantages of gene editing technologies, such as:
- Cost effectiveness
- Short development time
"We are applying CRISPR/Cas9 technology to create Knockouts and Knockins in outbred, and more fragile inbred genetic backgrounds such as C57BL/6."
You will benefit from:
- Three independent genetically modified lines
- Freedom to operate thanks to our unique IP portfolio, including a license from Broad Institute (MIT)
- Off-target measurement
- Short development time
CRISPR/Cas9-based mouse model development
Get in touch about
Let us know how we can help
Oops! Something went wrong while submitting the form.